bioRxiv Science⌕ Search

bioRxiv · 10.1101/2023.04.17.537131

Modulation of Pain Perception and Tolerance Following Treadmill Running with Different Intensities

Abstract

ObjectiveThis study aimed to compare the effects of three intensities of treadmill running on pain perceptions in healthy individuals. And investigate the role of endogenous pain modulation in the exercise-induced hypoalgesia (EIH) effects. MethodsSixty-six healthy female individuals were included in this study and were randomly assigned to one of three treadmill running intensities for 35 minutes: 40% of their reserve heart rate (HRR), 55% HRR, or 70% HRR. The EIH effects were assessed by the changes of pressure pain thresholds (PPT) and pressure pain tolerance thresholds (PPTol) at multiple time points. The assessments were conducted prior to the treadmill running session every 5 minutes during the exercise bout, and at 5 minutes, 10 minutes, and 24 hours post-exercise. The conditioned pain modulation (CPM) was also measured to determine the functions of endogenous pain modulation. ResultsCompared with baseline, there was a significant increase of PPT and PPTol at arm and leg in all groups during running and 5-10min follow-ups. The PPT and PPTol changes of moderate and low intensity groups were significantly higher than the high intensity group during running and 24h after running. While the CPM responses of high intensity group were significantly reduced compared with other groups at 24h follow-up. ConclusionModerate and low intensity running may trigger the endogenous descending inhibition and elicit significant EIH effects following running and persisting over 24h. While the high intensity running only induced limited EIH effects for the activation of both descending pain inhibition and facilitation, with reduced CPM responses. Thus, the pain perception changes following exercises may reveal the potential mechanisms of EIH induced via exercises with different intensities. New findingsWhat is the central question of this study? Both the primary analgesia effect (EIH) and secondary pain allodynia (delayed onset muscle soreness) may occur following exercises, possibly due to the interaction between endogenous pain modulation and exercise intensities. What is the difference in the changes of primary and secondary pain perceptions following exercise with different intensities? What is the main finding and its importance? Moderate and low intensity running induced acute and long-lasting EIH effects via the effective activation of descending inhibition, while the high intensity running may trigger the descending facilitation and attenuate both the acute and long-lasting EIH effects. This result preliminarily explained the non-liner effect of exercise intensity on the acute EIH responds.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Xu, Z.-H., An, N., Chang, J. R., Yang, Y.-L.. 2023-04-17. Modulation of Pain Perception and Tolerance Following Treadmill Running with Different Intensities. https://doi.org/10.1101/2023.04.17.537131

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

The Unreasonable Effectiveness of Cell Types in Describing Neuronal Physiological Features

Single-cell RNA sequencing (scRNA-seq) captures detailed gene expression profiles at scale, while patch-clamp recordings measure intrinsic neuronal electrophysiological properties. Modeling the relations between these two modalities remains a challenge. Here, we compare how well electrophysiological features can be predicted by traditional transcriptomic cell type classification, representations derived from a foundational model (scGPT) pretrained on large-scale scRNA-seq datasets, ion channel-coding genes, and highly variable genes. Using paired transcriptomic and electrophysiological patch-sequencing data from 495 human neurons from neurosurgical tissue, we find that cluster-level cell type representations consistently outperform highly variable gene selection, ion channel gene selection, and context-enriched scGPT embeddings. Notably, performance varies across model architectures and initializations, and the best results are obtained by combining the outputs of separate cell type and scGPT-based models. Together, these findings suggest that traditional discrete cellular classification is highly effective in predicting physiological features. For maximum performance it can be complemented by pretrained transformer models.

neuroscience↗

A nonlinear inhibition pathway underlying cortical responses to tuned holographic optogenetic perturbations

Optogenetics enables causal manipulation of cortical activity. Perturbation responses can be counterintuitive due to network interactions, making theory essential for predicting them. Existing approaches often rely on linear approximations, which fail for many biologically relevant perturbations. Here we develop a nonlinear theory of responses to holographic perturbations in cell-type-specific recurrent networks with structured connectivity. We fit a nonlinear model to mouse V1 data, which shows cotuned-ensemble suppression: perturbing spatially clustered neurons with similar preferred orientations yields markedly stronger short-range suppression than perturbing untuned ensembles. We show that cotuned-ensemble suppression arises from a feature-tuned, nonlinear inhibition pathway implicating somatostatin-positive (SST) interneurons. The theory predicts that cotuned ensembles suppress parvalbumin-positive (PV) neurons but facilitate SST neurons, and links the degree of cotuned-ensemble suppression or facilitation to the variance of the SST response. This framework identifies mechanisms by which nonlinear inhibition sculpts cortical dynamics and establishes a predictive basis for targeted optogenetic interventions.

neuroscience↗

Proteomic signatures of APOE ε4 across human tissues and cell types in Alzheimers disease

The apolipoprotein E {varepsilon}4 (APOE {varepsilon}4) allele is the strongest genetic risk factor for late-onset Alzheimers disease (AD). However, the underlying molecular mechanisms remain unclear. This study included 1691 participants from the Religious Orders Study and Rush Memory and Aging Project (ROSMAP), 1226 participants from the Accelerating Medicines Partnership - Alzheimers Disease (AMP-AD) Diverse Cohorts Study, and 735 participants from the Alzheimers Disease Neuroimaging Initiative (ADNI). To characterise APOE {varepsilon}4 molecular effects, we analysed proteomic data from plasma, cerebrospinal fluid (CSF), and induced pluripotent stem cell (iPSC)-derived astrocytes and neurons, as well as transcriptomic and proteomic data from multiple brain regions. The association of APOE {varepsilon}4 with AD neuropathology was also examined. APOE {varepsilon}4 carriers shared a plasma proteomic signature enriched for immune processes, irrespective of AD diagnosis. A machine learning classifier trained on this signature discriminated APOE {varepsilon}4 carriers from non-carriers in an independent cohort using CSF proteomics. APOE {varepsilon}4 carriage was associated with higher Braak stages and Consortium to Establish a Registry for Alzheimers Disease (CERAD) score. However, only limited APOE {varepsilon}4-associated transcriptomic and proteomic changes were observed in bulk brain tissue, with poor cross-layer concordance. Proteomic analyses of iPSC-derived astrocytes and neurons further revealed cell-type-specific APOE {varepsilon}4-associated changes. APOE {varepsilon}4 is associated with a consistent proteomic signature across plasma and CSF. Its molecular effects in the brain differ across cell types, brain regions and molecular layers. These findings support the need for cell-type-resolved multi-omic studies to elucidate how APOE {varepsilon}4 confers AD risk.

neuroscience↗